Developing drug candidates to the proof of concept
We offer preclinical studies with a focus on respiratory diseases such as asthma, COPD, infection, and pulmonary fibrosis. For this purpose, we use disease-relevant and toxicological test systems. Our studies are performed by a highly qualified and dedicated team of immunologists, biologists, toxicologists, and technical assistants. Based on our excellent scientific expertise, we assist our clients in the development of preclinical concepts.
Our experience with partners from the biotech and pharmaceutical industries forms the basis for scientific solutions and custom-tailored services. We assist our clients in developing preclinical testing strategies aimed at ensuring regulatory acceptance.
Different cooperation schemes can be offered: from a joint publication to services aimed at advancing a drug product to the next development phase.